Baebies & Medical Horizons Parntership
- Rolando Arpi
- Dec 14, 2022
- 2 min read
Updated: May 12
December 14, 2022 – Durham, NC, and Florence, Italy.

Baebies announced its new partnership with medical device supplier Medical Horizons S.r.L to help bring newborn screening solutions to a greater number of countries in Europe.
"It is a great honor for us to continue to grow this cooperation beyond the borders of Italy with the Baebies team, who share our passion for serving a delicate sector such as that of childhood pathologies,” stated Guido Osti, CEO of Medical Horizons.
“Medical Horizons has the right technical skill and commercial strategy to help us successfully expand adoption of our innovative newborn screening technology,” said Paul Roesch, Sr. Director of Newborn Screening at Baebies. “Our partnership is an optimal way to help more European countries easily add lysosomal storage disorders (LSD) to their newborn screening panels.”
Babies born with rare genetic disorders, such as LSDs, may not develop symptoms of the disorder within days, months, or even years after birth. For this reason, it is critically important that advances in therapies for these conditions be matched with the implementation of newborn screening programs to help quickly identify children who need treatment. In many cases, therapies achieve the best possible health outcomes if they are initiated before children become clinically symptomatic.
“At Medical Horizons, we are focused on delivering the next generation of medical technology to the Italian and European healthcare markets. The Baebies digital microfluidics solution for screening newborns for LSDs, including Pompe, Mucopolysaccharidosis type I (MPS I), Fabry, and Gaucher, on the SEEKER® platform allows treatment to begin before symptoms or permanent health problems occur,” announced Mr. Osti.
About Baebies
Baebies is a growth-stage medical device company developing innovative products to enable early disease detection and multifunctional diagnostics for syndromic testing for children and adults. Guided by the vision that "everyone deserves a healthy start," Baebies delivers millions of tests globally every year to save lives and make lives better. Baebies is a pioneer in digital microfluidics, which maximizes diagnostic yield from low-volume samples.
About Medical Horizons
Medical Horizons was created to identify medical innovations worldwide that had the potential to become innovative new products and then develop their commercialization with the most selected sales network. Medical Horizons’ expertise includes understanding the commercial interest that innovative devices will have for the medical market, to ensure that these products will meet the perceived need of prospective acquirers.